Applied Evidence

Diabetes in the elderly: Matching meds to needs

Author and Disclosure Information

 

From The Journal of Family Practice | 2018;67(7):408-410,412-415.

References

Combining antidiabetes agents

Combination therapy is often needed as T2DM progresses, even though strict glucose control is generally not recommended for the elderly.31 The American Geriatrics Society advises avoiding additional medications other than metformin to achieve an A1C level below 7.5% in most older adults.

However, for older patients already taking metformin who are not at their A1C goal, consider adding a second agent, if not contraindicated. Potential agents include a GLP-1 RA, SGLT-2 inhibitor, DDP-4 inhibitor, or short-acting sulfonylurea (glipizide). Alternatively, basal insulin may be added. However, avoid combining a sulfonylurea with insulin, which greatly increases the risk of hypoglycemia.32 Consider adding a GLP-1 RA or basal insulin if the patient is not at his/her target A1C on oral therapy with multiple agents.3

CORRESPONDENCE
Barbara Keber, MD, Glen Cove Hospital, 101 St. Andrews Lane, Glen Cove, NY; bkeber@northwell.edu.

Pages

Recommended Reading

T1D neuropathy declines as glycemic control improves
MDedge Family Medicine
Switch back to human insulin a viable money saver
MDedge Family Medicine
Eversense CGM shown safe, accurate for 180 days in adolescents
MDedge Family Medicine
Research provides more evidence of a maternal diabetes/autism link
MDedge Family Medicine
Obesity didn’t just happen overnight
MDedge Family Medicine
Diabetes patients pushed into high-deductible plans
MDedge Family Medicine
Intensive treatment for T2D pays off in the long run
MDedge Family Medicine
Alirocumab’s benefit greater in diabetes patients: ODYSSEY Outcomes
MDedge Family Medicine
Pancreas volume studies may offer insight into T1DM
MDedge Family Medicine
High-bleeding-risk AF patients cut stroke risk with Amplatzer Amulet
MDedge Family Medicine